Celularity

CELU49

Penny Stock

$2.97arrow_drop_up1.88%$0.05

Penny Stock

CELU49

$2.97

arrow_drop_up1.88%$0.05

Penny Stock

Performance History

Key Stats
Open	$2.71
Prev. Close	$2.77
EPS	-104.78
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$60.89M
PE Ratio	-

	LOW	HIGH
Day Range	2.55	2.95
52 Week Range	1.31	7.97

Ratios







EPS	-104.78

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Celularity (CELU)

Celularity Inc. (CELU) is a leading biotechnology company that focuses on developing innovative cell therapeutics for the treatment of various diseases. The company is known for its groundbreaking research in the field of regenerative medicine and its commitment to improving patient outcomes. With a strong portfolio of intellectual property and a team of world-class scientists, Celularity is well positioned to drive advancements in the field of cellular therapy.

One key aspect of Celularity's success is its stock performance. Over the years, CELU has shown impressive growth, with its stock price consistently increasing. Investors who have held onto CELU stock have benefited from its upward trajectory. The stock price history reflects the company's consistent progress and market confidence in its innovative products and technologies. As a result, Celularity Inc. has gained a substantial market cap, solidifying its position as a leading player in the biotechnology industry.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Headquarters: Florham Park
Employees: 225
Exchange: NASDAQ

Keep an eye on Celularity

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Celularity (CELU)?

Celularity (CELU) has a market capitalization of $64.2M. The average daily trading volume is 2.98, indicating the stock's liquidity and investor engagement.

help

What is Celularity's (CELU) price per share?

The current price per share for Celularity (CELU) is $2.98. The stock has seen a price change of $0.06 recently, indicating a 1.88% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Celularity (CELU)?

For Celularity (CELU), the 52-week high is $7.97, which is 167.9% from the current price. The 52-week low is $1.31, the current price is 126.24% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Celularity (CELU) a growth stock?

Celularity (CELU) has shown an average price growth of -6.8% over the past three years. It has received a score of 97 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Celularity as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Celularity (CELU) stock price performance year to date (YTD)?

As of the latest data, Celularity (CELU) has a year-to-date price change of 6.4%. Over the past month, the stock has experienced a price change of 41.33%. Over the last three months, the change has been -4.34%. Over the past six months, the figure is -5.25%.

help

Is Celularity (CELU) a profitable company?

Celularity (CELU) has a net income of -$196.3M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 29.66% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -84.02% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $22.77M, with a revenue growth rate of 26.68%, providing insight into the company's sales performance and growth. The gross profit is $6.76M. Operating income is noted at -$76.48M. Furthermore, the EBITDA is -$35.9M.

News

REGENERATIVE MEDICINE

Oct 16, 2024

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.

CELULARITY INC.

RICHARD J. BERMAN

PUBLIC COMPANY DIRECTOR

FINANCE VETERAN

SHAREHOLDER VALUE

Aug 28, 2024

Celularity Appoints Richard J. Berman to its Board of Directors

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

CALENDAR OF EVENTS

Jun 3, 2024

Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting

MAJOR SHAREHOLDER ANNOUNCEMENTS

May 24, 2024

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Celularity (CELU)

Keep an eye on Celularity

Frequently Asked Questions

What is the market capitalization of Celularity (CELU)?

What is Celularity's (CELU) price per share?

What is the 52-week high and low for Celularity (CELU)?

Is Celularity (CELU) a growth stock?

What is Celularity (CELU) stock price performance year to date (YTD)?

Is Celularity (CELU) a profitable company?

News

Take Your Investments to a Whole New Level